LYNX1 CAPITAL MANAGEMENT LP – Aerovate Therapeutics, Inc. Transaction History
LYNX1 CAPITAL MANAGEMENT LP portfolio value:
$4.58M
portfolio value
LYNX1 CAPITAL MANAGEMENT LP quarter portfolio value change:
+6.08%
quarter
Aerovate Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +44.31% | 84.88K shares | 1.58M | $16.58 | 276.44K |
| Q2 2022 | share | Increase | +186.02% | 124.58K shares | 1.76M | $15.63 | 191.56K |
| Q1 2022 | share | Increase | 0.00% | 66.97K shares | 1.22M | $18.33 | 66.97K |